Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Sayad Pierre Sargis received 3,846 Fennec Pharmaceuticals Inc. shares as an award (Form 4)
Traded Oct 12, 2026 · Filed Oct 13, 2026
On Oct 12, 2026, Sayad Pierre Sargis (Chief Medical Officer) received 3,846 Fennec Pharmaceuticals Inc. shares as an award at US$5.53 for US$21,268, leaving 13,533 shares. Filed Oct 13, 2026 (Form 4).
- Awarded
- 3,846 shares
- Price
- US$5.53
- Value
- US$21,268
- Holding after
- 13,533 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | Common Shares | Award | 3,846 | US$5.53 | 13,533 | Direct |
Source
Related
- Fennec Pharmaceuticals Inc.
- Sayad Pierre Sargis
- Fennec Pharmaceuticals Inc. shareholders
- Form 4 · Sayad Pierre Sargis · Oct 1, 2026
- Form 4 · Sayad Pierre Sargis · Aug 31, 2026
- Form 4 · Sayad Pierre Sargis · Aug 3, 2026
- Form 4 · Sayad Pierre Sargis · Jul 1, 2026
- Form 4 · Sayad Pierre Sargis · Jun 1, 2026
- Schedule 13G/A · Orin Hirschman · Oct 19, 2026
- Form 4 · Andrade Robert · Oct 13, 2026
- Form 4 · Cioffi Christiana Marie · Oct 13, 2026
- Form 4 · Evans Terry L · Oct 13, 2026
- Form 4 · Hackman Jeffrey S. · Oct 13, 2026